Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

Gates Foundation

Women's_Health

Women’s Health Video Recap—October 29, 2025

This biweekly women’s health video highlights policy/regulatory updates,…

Women's_Health

Top Women’s Health News: Video summary (Oct 1 – Oct 14, 2025)

This video summary includes developments across women’s health highlighting FDA…

Public_Health

Public Health Weekly News - September 26th 2025

Public Health Update: Huntington’s Gene Therapy, Low-Cost HIV PrEP, New…

Categories

Endocrinology News
Immunology News
Our Insights
Hematology News
Case studies
Oncology News
BioPharma and Tech News
Lucid Diligence Brief
BioPharma Strategy, CI and AI Guides
Conference Previews
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news
Obesity News

Recent Posts

AI in Healthcare and Digital Health Video Recap—November 18, 2025
Obesity Today—November 18, 2025
Endocrinology Video Recap—November 18, 2025
Endocrinology Today—November 18, 2025
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics

Tags

adrabetadex Adrenal Insufficiency ADT Alvotech Aptose Biosciences ATR inhibitor BATURA Caplyta Circle Pharma cladribine tablets CSF1R Deucravacitinib EASD EFORT Efzofitimod EHMSG Eli Lilly Mounjaro ENCELTO GEMMABio icobrain ILD safety IO Biotech Ionis Karyopharm Mediterranean diet NHS AI Imaging NRDD Observational analysis Olumiant PCORI Phase I trial Pneumococcal Disease pulmonary embolism Resalis Revuforj RGT-61159 SingHealth smoking cessation taletrectinib telomeres Thymidine kinase 2 deficiency TL1A trastuzumab deruxtecan VarmX xolair

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

AI in Healthcare and Digital Health Video Recap—November 18, 2025
Obesity Today—November 18, 2025
Endocrinology Video Recap—November 18, 2025
Endocrinology Today—November 18, 2025
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics

TAGS

adrabetadex Adrenal Insufficiency ADT Alvotech Aptose Biosciences ATR inhibitor BATURA Caplyta Circle Pharma cladribine tablets CSF1R Deucravacitinib EASD EFORT Efzofitimod EHMSG Eli Lilly Mounjaro ENCELTO GEMMABio icobrain ILD safety IO Biotech Ionis Karyopharm Mediterranean diet NHS AI Imaging NRDD Observational analysis Olumiant PCORI Phase I trial Pneumococcal Disease pulmonary embolism Resalis Revuforj RGT-61159 SingHealth smoking cessation taletrectinib telomeres Thymidine kinase 2 deficiency TL1A trastuzumab deruxtecan VarmX xolair

Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy